The genomic landscape of pediatric cancers: Implications for diagnosis and treatment. Read more about The genomic landscape of pediatric cancers: Implications for diagnosis and treatment.
RIT1 oncoproteins escape LZTR1-mediated proteolysis. Read more about RIT1 oncoproteins escape LZTR1-mediated proteolysis.
Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Read more about Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity.
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder. Read more about Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder.
CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency. Read more about CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency.
Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Read more about Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma.
Treg cells-the next frontier of cell therapy. Read more about Treg cells-the next frontier of cell therapy.
Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway. Read more about Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway.
